Bezafibrate lowers oxygen affinity of haemoglobin.
D019794:2,3-Diphosphoglycerate; D000755:Anemia, Sickle Cell / Q000188:drug therapy; D001629:Bezafibrate / Q000494:pharmacology* / Q000627:therapeutic use; D002994:Clofibrate / Q000494:pharmacology; D004163:Diphosphoglyceric Acids / Q000494:pharmacology; D004357:Drug Synergism; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006441:Hemoglobin A / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000378:metabolism*; D006801:Humans; D010100:Oxygen / Q000097:blood*; D012995:Solubility
D004163:Diphosphoglyceric Acids; D006451:Hemoglobin, Sickle; D019794:2,3-Diphosphoglycerate; D006441:Hemoglobin A; D002994:Clofibrate; D010100:Oxygen; D001629:Bezafibrate